NDC 0093-7664

Erlotinib

Erlotinib

Erlotinib is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Teva Pharmaceuticals Usa, Inc.. The primary component is Erlotinib Hydrochloride.

Product ID0093-7664_34a616f7-8301-4dba-bb2f-a27691e3e08e
NDC0093-7664
Product TypeHuman Prescription Drug
Proprietary NameErlotinib
Generic NameErlotinib
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2019-05-09
Marketing CategoryANDA / ANDA
Application NumberANDA091059
Labeler NameTeva Pharmaceuticals USA, Inc.
Substance NameERLOTINIB HYDROCHLORIDE
Active Ingredient Strength150 mg/1
Pharm ClassesKinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 0093-7664-56

30 TABLET, FILM COATED in 1 BOTTLE (0093-7664-56)
Marketing Start Date2019-05-09
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0093-7664-56 [00093766456]

Erlotinib TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA091059
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2019-05-09

Drug Details

Active Ingredients

IngredientStrength
ERLOTINIB HYDROCHLORIDE150 mg/1

Pharmacological Class

  • Kinase Inhibitor [EPC]
  • Protein Kinase Inhibitors [MoA]
  • Kinase Inhibitor [EPC]
  • Protein Kinase Inhibitors [MoA]

NDC Crossover Matching brand name "Erlotinib" or generic name "Erlotinib"

NDCBrand NameGeneric Name
0093-7662ErlotinibErlotinib
0093-7663ErlotinibErlotinib
0093-7664ErlotinibErlotinib
51991-890ErlotinibErlotinib Hydrochloride
51991-891ErlotinibErlotinib Hydrochloride
51991-892ErlotinibErlotinib Hydrochloride
59651-530ErlotinibErlotinib
59651-531ErlotinibErlotinib
59651-532ErlotinibErlotinib
59923-725ErlotinibErlotinib
59923-726ErlotinibErlotinib
59923-727ErlotinibErlotinib
63304-095ErlotinibErlotinib
63304-096ErlotinibErlotinib
63304-135ErlotinibErlotinib
68382-913ErlotinibErlotinib
68382-914ErlotinibErlotinib
68382-915ErlotinibErlotinib
70771-1521ErlotinibErlotinib
70771-1522ErlotinibErlotinib
70771-1523ErlotinibErlotinib
72485-217ErlotinibErlotinib hydrochloride
72485-218ErlotinibErlotinib hydrochloride
72485-219ErlotinibErlotinib hydrochloride
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.